Quipt Home Medical

  • "exceeding expectations, enriching lives"

  • 859-300-6455

    cole.stevens@myquipt.com

  • 1019 Town Drive

    Wilder, KY 41076

QUIPT HOME MEDICAL ANNOUNCES FILING OF FORM 40-F WITH SEC


  •   8:30AM EST

CINCINNATI, May 14, 2021 -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (TSXV:QIPT; OTCQX:PTQQD), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is pleased to announce that it has filed a Form 40-F Registration Statement (“Form 40-F”) with the United States Securities and Exchange Commission (the “SEC”), fulfilling a significant milestone in the process for the Company to list its common shares on The Nasdaq Capital Market (“Nasdaq”). Quipt will become a reporting issuer in the United States following effectiveness of the Form 40-F, in addition to being a reporting issuer in Canada. A copy of the Form 40-F is available on EDGAR, SEDAR and the Company's website at www.protechhomemedical.com.

Listing of the Company’s common shares on Nasdaq remains subject to the approval of Nasdaq and the satisfaction of all applicable listing and regulatory requirements, including the effectiveness of the Form 40-F. Following receipt of all required approvals, the Company will issue a press release announcing its first trading date on Nasdaq.

“Quipt’s rapidly growing operations are completely based in the United States, making the filing of our Form 40-F a significant steppingstone for the Company,” commented Greg Crawford, CEO and Chairman of Quipt. “We are striving to become a national leader in respiratory homecare in the United States and are excited to utilize a Nasdaq listing to meaningfully increase our Company’s awareness. With our robust balance sheet, continued operating momentum, and pipeline of acquisitions, we are excited to share our vision with a broader audience of investors.”

In connection with the Company’s application for listing on Nasdaq and filing of its Form 40-F, the Company’s auditor has concluded its review of the Q1 Fiscal 2021 financial statements for incorporation in the Form 40-F now filed with the SEC. The amended and restated interim financial statements the three months ended December 31, 2020 and 2019 and accompanying Management Discussion & Analysis (MD&A) are available at www.sedar.com. For additional clarification, please note there has been no material change to the previously reported Q1 Fiscal 2021 financial statements.